168 related articles for article (PubMed ID: 8535854)
1. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854
[TBL] [Abstract][Full Text] [Related]
2. Morphine-3-glucuronide: hyperglycemic and neuroendocrine potentiating effects.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res; 1995 Oct; 694(1-2):13-20. PubMed ID: 8974636
[TBL] [Abstract][Full Text] [Related]
3. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
Qian-Ling G; Hedner J; Björkman R; Hedner T
Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243
[TBL] [Abstract][Full Text] [Related]
4. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronide.
Molina PE; Hashiguchi Y; Ajmal M; Mazza M; Abumrad NN
Brain Res; 1994 Nov; 664(1-2):126-32. PubMed ID: 7895021
[TBL] [Abstract][Full Text] [Related]
5. Central opiate modulation of growth hormone and insulin-like growth factor-I.
Hashiguchi Y; Molina PE; Fan J; Lang CH; Abumrad NN
Brain Res Bull; 1996; 40(2):99-104. PubMed ID: 8724426
[TBL] [Abstract][Full Text] [Related]
6. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
7. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
8. Central effects of morphine and morphine-6-glucuronide on tissue protein synthesis.
Hashiguchi Y; Molina PE; Preedy VR; Sugden PH; McNurlan MA; Garlick PJ; Abumrad NN
Am J Physiol; 1996 Sep; 271(3 Pt 2):R619-25. PubMed ID: 8853383
[TBL] [Abstract][Full Text] [Related]
9. Effects of morphine metabolites on micturition in normal, unanaesthetized rats.
Igawa Y; Westerling D; Mattiasson A; Andersson KE
Br J Pharmacol; 1993 Sep; 110(1):257-62. PubMed ID: 8220887
[TBL] [Abstract][Full Text] [Related]
10. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
Baker L; Dye A; Ratka A
Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
12. Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.
Morrish GA; Foster DJ; Somogyi AA
Br J Clin Pharmacol; 2006 Mar; 61(3):326-35. PubMed ID: 16487227
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
Easterling KW; Holtzman SG
Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
[TBL] [Abstract][Full Text] [Related]
15. Contribution of excitatory amino acids to morphine-induced metabolic alterations.
Meijerink WJ; Molina PE; Lang CH; Abumrad NN
Brain Res; 1996 Jan; 706(1):123-8. PubMed ID: 8720499
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
17. The influence of inhibition of probenecid sensitive transporters on the central nervous system (CNS) uptake and the antinociceptive activity of morphine-6-glucuronide in rats.
Lötsch J; Schmidt R; Vetter G; Schmidt H; Skarke C; Niederberger E; Geisslinger G; Tegeder I
Neurosci Lett; 2002 Aug; 329(2):145-8. PubMed ID: 12165398
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses.
Knych HK; Kanarr K; Fang Y; McKemie DS; Kass PH
Vet Anaesth Analg; 2022 Nov; 49(6):634-644. PubMed ID: 35999165
[TBL] [Abstract][Full Text] [Related]
19. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
[TBL] [Abstract][Full Text] [Related]
20. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
